GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
264
c/glp1science·posted 4 months ago by u/split_dose_sceptic

[PSA] incretin is not what most of this community thinks it is

Needs Source Receipts ×3

incretin is not what most of this community thinks it is, written plainly and without the jargon that usually swallows this topic.

The mental model, in four steps, that makes the rest of this site legible.

One: gut hormones amplify the insulin response to food. Two: agonists at those receptors act peripherally on insulin secretion and gastric emptying, and centrally on appetite. Three: structural modification gives them a long half-life, so exposure is smooth and weekly. Four: tolerance develops to some effects and not to others.

From those four, most of what the experience boards report falls out: why the side effects cluster early, why they settle at a stable dose, why appetite reduction persists, and why the scale and the appetite move on different clocks.

Went looking for human data on a mechanism everybody here asserts. Found preclinical work and one small study. That was clarifying.

Started reading limitations sections first. It has changed how much weight I give to almost everything posted here.

Tell me where this is wrong. That is the useful part of posting it.

417 up / 153 down73% upvoted14 commentsid wtzmpk19 Mar 2026

14 comments

8 in this archive, depth 3

best — the order this archive was captured in

u/titration_marshalmod · c/semaglutide44 points·4 months ago·edited

GIP receptor biology is genuinely unsettled — there is a live argument about agonism versus antagonism at the receptor — and the clinical results are robust regardless, which is an uncomfortable and interesting position.

replysharereportpermalink
u/georgi_chowdhury14 points·4 months ago

This. Albumin binding and modification are why the half-life is what it is, and it is a design decision rather than an accident.

replysharereportpermalink
u/anya_salgado7 points·4 months ago

Are we talking about receptor affinity or clinical potency?

replysharereportpermalink
u/hassan_castellanos8 points·4 months ago

Agreed — the incretin effect is the load-bearing concept and everything downstream reads differently once you have it.

replysharereportpermalink
u/enzo_petrescu31 points·4 months ago

Push back: a receptor being expressed in a tissue does not tell you the agonist reaches it at therapeutic exposure.

replysharereportpermalink
u/formulary_fighterappeals24 points·4 months ago·edited

Push back: a receptor being expressed in a tissue does not tell you the agonist reaches it at therapeutic exposure.

Adding the caveat the paper itself makes in its limitations section, which is stronger than anything in this thread.

replysharereportpermalink
u/greta_lokken11 points·4 months ago

incretin effect first, then everything else in this board makes sense

replysharereportpermalink
load more comments (1) →
About c/glp1science

The mechanism layer: incretin physiology, receptor distribution, gastric emptying, central appetite signalling, glucagon-receptor contribution, amylin co-agonism, and the pharmacokinetics that make weekly dosing possible. Papers get cited by journal and year or they get a [needs source] reply.

50kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/glp1science rules
  1. Cite the paper: journal, year, first author. Links optional, citation mandatory.
  2. Mechanistic speculation is welcome if flaired as speculation.
  3. No extrapolating rodent data to human dosing without saying that is what you are doing.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.